THE SENATE

THE THIRTIETH LEGISLATURE

REGULAR SESSION OF 2019

 

COMMITTEE ON COMMERCE, CONSUMER PROTECTION, AND HEALTH

Senator Rosalyn H. Baker, Chair

Senator Stanley Chang, Vice Chair

 

NOTICE OF HEARING

 

 

DATE:

Tuesday, February 5, 2019

TIME:

9:00AM

PLACE:

Conference Room 229

State Capitol

415 South Beretania Street

 

A G E N D A

 

SB 1213

      Status & Testimony

RELATING TO PROCUREMENT FILING FEE.

Requires a party initiating a bid challenge to pay the Department of Commerce and Consumer Affairs a non-refundable filing fee for contracts with an estimated value of $500,000 or more.

 

CPH, WAM

SB 1214

      Status & Testimony

RELATING TO TRANSITIONAL AUTHORITY IN THE MORTGAGE INDUSTRY.

Implements section 106 of the Economic Growth, Regulatory Relief, and Consumer Protection Act, P.L. 115-174, by providing 120-day temporary authority to originate loans in this State for loan originators moving from a depository institution to a non-depository institution and state-licensed loan originators moving interstate.

 

CPH, JDC

SB 1215

      Status & Testimony

RELATING TO MORTGAGE SERVICERS.

Authorizes the Commissioner of Financial Institutions to modify requirements and make new requirements in chapter 454M, Hawaii Revised Statutes, to implement changes and improvements made to NLMS.  Authorizes the Commissioner of Financial Institutions to issue cease and desist orders against licensees and unlicensed persons and to enter into consent orders.

 

CPH, JDC

SB 1352

      Status & Testimony

RELATING TO INDUSTRIAL HEMP.

Clarifies that financial institutions are authorized to conduct business with persons and entities that lawfully deal with industrial hemp.

 

CPH, JDC/WAM

SB 537

      Status & Testimony

RELATING TO CONSUMER PROTECTION.

Transitions from lump sum deferred deposit transactions to installment-based small dollar loan transactions.  Specifies various consumer protection requirements for small dollar loans.  Beginning 1/1/2020, requires licensure for small dollar lenders that offer small dollar loans to consumers.  Specifies licensing requirements for small dollar lenders.  Authorizes the division of financial institutions to appoint 2.0 FTE examiner positions, funded via the compliance resolution fund, to carry out the purposes of the small dollar installment loan program.

 

CPH, WAM

SB 19

      Status & Testimony

RELATING TO SURPLUS LINES.

Amends the calculation of surplus lines insurance premium tax to tax the entirety of the premium using the rate established by Hawaii statute regardless of location of risk.

 

CPH, WAM

SB 817

      Status & Testimony

RELATING TO SELF-SERVICE STORAGE.

Authorizes the sale of stored property insurance by self-service storage facility owners under certain conditions.  Requires self-service storage facility owners to hold a limited lines license in order to sell, solicit, or offer coverage under a stored property insurance policy.

 

CPH, WAM

SB 1465

      Status & Testimony

RELATING TO TREATMENT INSURANCE BENEFITS.

Requires mental health insurers to cover certain expenses related to petitions and hearings for obtaining assisted community treatment for persons.

 

CPH, WAM

SB 1027

      Status & Testimony

RELATING TO HEARING AIDS.

Requires health insurance policies and contracts issued after 12/31/19 to provide coverage for the cost of hearing aids at a minimum of $1,500 per hearing aid for each hearing-impaired ear every thirty-six months in their base plans.

 

CPH, WAM

SB 1401

      Status & Testimony

RELATING TO PHARMACY BENEFIT MANAGERS.

Prohibits pharmacy benefit managers from engaging in self-serving business practices.  Replaces registration requirement with license requirement for pharmacy benefit managers.  Increases pharmacy benefit manager reporting requirements to the insurance commissioner.

 

Pending re-referral to:

CPH, WAM

SB 1521

      Status & Testimony

RELATING TO PHARMACY BENEFIT MANAGERS.

Establishes requirements for pharmacy benefit managers and maximum allowable cost, including the ability of pharmacies to receive comprehensive maximum allowable cost lists and bring complaints within the purview of the department of commerce and consumer affairs, rather than the department of health.  Requires pharmacy benefit managers to disclose where an equivalent drug can be obtained at or below the maximum allowable cost when a maximum allowable cost is upheld on appeal and allow contracting pharmacies to reverse and rebill claims if the pharmacy benefit manager establishes a maximum allowable cost that is denied on appeal and pay the difference to the contracting pharmacies.  Clarifies the available penalties for violations of maximum allowable cost requirements.

 

CPH, JDC

 

Decision Making to follow, if time permits.

 

Click here to submit testimony.

 

Testimony may be submitted up to 24 hours prior to the start of the hearing.

 

FOR AMENDED NOTICES:  Measures that have been deleted are stricken through and measures that have been added are underscored.  If a measure is both underscored and stricken through, that measure has been deleted from the agenda.

 

If you require auxiliary aids or services to participate in the public hearing process (i.e., interpretive services (oral or written), ASL interpreter, or wheelchair accessibility), please contact the committee clerk at least 24 hours prior to the hearing so that arrangements can be made.

 

FOR FURTHER INFORMATION, PLEASE CALL THE COMMITTEE CLERK AT (808) 586-6070.

 

 

 

_____________________________________

Senator Rosalyn H. Baker

Chair